Navigation Links
Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
Date:1/8/2008

BOSTON, Jan. 8 /PRNewswire/ -- Surface Logix today announced positive results in the Company's Phase 2a clinical trial of SLx-2101 in hypertension. The randomized, double-blind, placebo-controlled crossover Phase 2a study in 60 patients with uncontrolled hypertension demonstrated that SLx-2101 caused clinically significant reductions in blood pressure and was well tolerated. The trial was designed to examine the safety, tolerability and effect on blood pressure in patients of repeat oral doses of SLx-2101 once daily for up to 14 days.

"These data confirm the promise of efficacy seen in earlier clinical trials, and we plan to initiate a Phase 2b study of SLx-2101 in hypertension in the third quarter of 2008," said Jim Mahoney, President and CEO of Surface Logix. "We believe that with our demonstrated 24-hour coverage from once daily dosing and excellent tolerability profile, we will be able to uniquely position SLx-2101 in several segments of the hypertension market."

SLx-2101 is an oral, potent, selective, fast-onset, long-acting PDE5 inhibitor. Other PDE5 inhibitors have traditionally been used to treat erectile dysfunction (ED). SLx-2101 was designed specifically to expand the therapeutic potential of PDE5 inhibition beyond ED into larger cardiovascular markets such as hypertension. SLx-2101 is uniquely positioned among the known PDE5 inhibitors to address cardiovascular disease because, compared to currently marketed PDE5 drugs, SLx-2101 preferentially distributes into cardiovascular tissue. With its large volume of distribution, SLx-2101 achieves sustained plasma levels and a long duration of action, without showing accumulation upon repeat dosing. This allows for daily or on demand dosing with a predictable response in a number of cardiovascular disorders that currently marketed PDE5 therapies cannot adequately address.

"To achieve efficacy in cardiovascular disease, your compound has to get into the right tissues," commented Dr. Pau
'/>"/>

SOURCE Surface Logix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Surface Logix, Inc. to Present at the Piper Jaffray Health Care Conference
2. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
3. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
4. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
5. Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the OARSI 2007 World Congress on Osteoarthritis
6. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
7. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
8. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
9. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
10. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
11. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014  Casen Buswell has a rare vascular condition ... His case is one of only 14 known cases of ... hospital in the United States , and ... with the dual wave-length laser, is Methodist Children,s Hospital, a ... . Using a laser available in South Texas ...
(Date:9/18/2014)... Sept. 18, 2014   Fruit Street Health ... initial seed round of funding. The ... by a series of individual investors, the majority of ... in the initial round are; Houston Cardiology Consultants ... Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
(Date:9/18/2014)... -- Pharma IQ, after huge ... Serialisation Countdown calendar to cover the years 2014 - ... shows the serialisation requirements around the globe and ... force. For companies dealing with international markets, ... "when" they will have to comply with new regulations ...
Breaking Medicine Technology:Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar 2
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... to discuss first quarter 2011 financial results, as well as ... at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time; 2:00 ... ended March 31, 2011 will be released earlier that day. ...
... 2011 / PRNewswire/ -- Fleming Pharmaceuticals, ... iodide product indicated for thyroid protection in radiation emergencies ... necessary to ramp up production to meet increased domestic ... an over-the-counter iodide solution which, when taken orally, saturates ...
Cached Medicine Technology:Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast 2Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield® 2
(Date:9/18/2014)... 18, 2014 Ben Quirk, CEO of ... Jr. Leadership Award by the Savannah Science Seminar in ... wellness throughout the nation and especially in Savannah. , ... said Ben. “The Savannah Science Seminar is an amazing ... multiple generations have gone through the program,” he added. ...
(Date:9/18/2014)... to pay higher employee contributions for their health insurance, ... about the impact of the Patient Protection and Affordable ... by the Darla Moore School of Business at the ... Wright, a professor in strategic human resource management, directs ... The survey is distributed to more than 560 CHROs ...
(Date:9/18/2014)... 2014 ChopChop founder Sally Sampson ... Yonah Kalikow, 10-year-old Massachusetts’s winner of the First Lady’s Healthy ... the classic Middle Eastern bean dip. Watch as Bill and ... can create their own healthy dips at home. The cooking ... annual Let’s Talk About Food Festival in Copley ...
(Date:9/18/2014)... A sold-out crowd of more than ... supported United Way of Westchester and Putnam ... event Monday, Sept. 15. Proceeds from the event will ... and Putnam, such as providing healthy foods to low-income ... risky behaviors like drug and alcohol usage. , Two ...
(Date:9/18/2014)... broadly effective vaccines to prevent the spread of illnesses ... has been made along these lines, there are still ... from these devastating diseases. , So what are ... At Caltech, Nobel Laureate David Baltimore and his colleagues ... vaccines introduce substances such as antigens into the body ...
Breaking Medicine News(10 mins):Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Survey: Fortune 500 employees can expect to pay more for health insurance 2Health News:Survey: Fortune 500 employees can expect to pay more for health insurance 3Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 2Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 3Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 2Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 3Health News:A new way to prevent the spread of devastating diseases 2Health News:A new way to prevent the spread of devastating diseases 3Health News:A new way to prevent the spread of devastating diseases 4Health News:A new way to prevent the spread of devastating diseases 5
... Food and Drug Administration, seeking marketing authorization for Zometa ... broad range of tumor types. These include prostate and ... approved. The spread of cancerous cells from the original ... called skeletal related events like fractures, compression of ...
... more heart-friendly products has been developed by European scientists. ... UK and colleagues, describe how they boosted the production ... tomatoes. Rutin is a flavonol, part of a larger ... be a powerful antioxidant.// ,The researchers noticed ...
... As there is so much to do and remember ... uncommon. ,Many people find prolonged stress and ... and even personality changes. Dramatic alterations in memory and ... Alzheimer's disease. // ,The fundamental cause of dementia ...
... an infectious disease transmitted by mosquitoes.It is characterised by ... severe forms of this disease can lead to death ... countries.// ,Hence eradication of this disease involves the ... in southern Asia, villagers spray the inside of their ...
... with heart disease are more likely to have severe symptoms ... monthly menstrual cycle, according to new research from England. ... which occurs when there is insufficient oxygen supply to the ... of heart disease. Researchers from the Cardiothoracic Centre report in ...
... the US recommend that everyone over 65 should get a ... making you more prone to infection. That's why it may ... Mayo Clinic in the US also urge people over 65 ... you from pneumonia, meningitis, and various other serious infections. The ...
Cached Medicine News:
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...
30, 6.0mm from end...
...
Medicine Products: